Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for HERON THERAPEUTICS, INC. /DE/ in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
RC
Rubric Capital Management LP
13D · 15.9%
|
30.0M | 15.74% | Unchanged | 2022 | 0.1% | |
|
Shares held by quarter
Peak holding30.0M (Q4'25)
Change over 8 quarters+3.3M
Share of the company15.740%
Disclosed stake13D · 15.9%
|
||||||
|
CC
Clearline Capital LP
|
11.4M | 5.96% | −851.3K (−7.0%) | 2022 | 0.3% | |
|
Shares held by quarter
Peak holding12.2M (Q4'25)
Change over 8 quarters+9.2M
Share of the company5.960%
|
||||||
28 more super investors behind a free account
See every manager holding HERON THERAPEUTICS, INC. /DE/, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$2.34M | 5.5M | 2.87% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$1.57M | 3.7M | 1.93% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding HERON THERAPEUTICS, INC. /DE/ and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
DR
David Rosen
5%+ holder
13D · 15.9%
|
30.0M | 15.74% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
MA
Morgan Adam
Insider
|
8.9M | 4.65% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company4.650%
|
||||||
10 more holders behind a free account
See every insider and 5%+ holder of HERON THERAPEUTICS, INC. /DE/.
Sign up freeLoading...